Antacid Melts Lozenge
NDC 68229-800
Product Information
Antacid Melts (calcium carbonate 250mg) is a OTC MONOGRAPH DRUG-approved product labeled by Quest Products, Llc. This medication is typically used as a blood coagulation factor [epc]. It is supplied as a yellow lozenge for oral administration. This product entry covers the primary NDC 68229-800 and 5 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
CA Code Structure Chart
Product Details
What is NDC 68229-800?
What are the uses of this product?
What are Active Ingredients of this product?
- CALCIUM CARBONATE 250 mg/1 - Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CALCIUM CARBONATE (UNII: H0G9379FGK)
- CALCIUM CATION (UNII: 2M83C4R6ZB) (Active Moiety)
- CARBONATE ION (UNII: 7UJQ5OPE7D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STRAWBERRY (UNII: 4J2TY8Y81V)
- ACACIA (UNII: 5C5403N26O)
- SODIUM BICARBONATE (UNII: 8MDF5V39QO)
- SORBITOL (UNII: 506T60A25R)
- CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MALTODEXTRIN (UNII: 7CVR7L4A2D)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2742640 - calcium carbonate 250 MG Oral Lozenge
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.